Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.
作者信息
Romero Roberto, Stanczyk Frank Z
出版信息
Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30.
Abstract
摘要
相似文献
1
Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.孕酮与己酸17α-羟孕酮不同：对产科实践的启示。
Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30.
2
Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.阴道用黄体酮或己酸17-α-羟孕酮预防早产：疗效与安全性的批判性审视
Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Epub 2015 Nov 10.
3
What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?用什么药物预防复发性早产：17-P 还是天然孕酮？
Obstet Gynecol Clin North Am. 2011 Jun;38(2):235-46, ix-x. doi: 10.1016/j.ogc.2011.02.014.
4
Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?己酸17α-羟孕酮在双胎妊娠中是否禁忌使用？
BJOG. 2015 Jan;122(1):6-7. doi: 10.1111/1471-0528.13066. Epub 2014 Oct 3.
5
The association between 17-hydroxyprogesterone caproate use and postpartum hemorrhage.己酸羟孕酮的使用与产后出血之间的关联。
Am J Obstet Gynecol MFM. 2019 May;1(2):144-147. doi: 10.1016/j.ajogmf.2019.04.004. Epub 2019 Apr 28.
6
Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.己酸17α-羟孕酮与感染风险的关联
Obstet Gynecol. 2015 Jul;126(1):103-8. doi: 10.1097/AOG.0000000000000881.
7
Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.阴道用黄体酮与肌肉注射己酸羟孕酮预防复发性早产的随机对照试验
Am J Obstet Gynecol. 2022 May;226(5):722.e1-722.e12. doi: 10.1016/j.ajog.2022.02.012. Epub 2022 Feb 19.
8
17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?17-α 羟孕酮己酸酯预防早产：我们从哪里来，我们如何走到这里，我们要去哪里？
Semin Perinatol. 2017 Dec;41(8):461-467. doi: 10.1053/j.semperi.2017.08.004. Epub 2017 Sep 22.
9
Immune effects of 17α-hydroxyprogesterone caproate.己酸17α-羟孕酮的免疫作用。
Am J Obstet Gynecol. 2022 Oct;227(4):671-675. doi: 10.1016/j.ajog.2022.06.056. Epub 2022 Jun 29.
10
Vaginal Progesterone Is Associated with Intrahepatic Cholestasis of Pregnancy.阴道用黄体酮与妊娠肝内胆汁淤积症有关。
Am J Perinatol. 2023 Aug;40(11):1158-1162. doi: 10.1055/a-2081-2573. Epub 2023 Apr 26.
引用本文的文献
1
Challenges in Using Progestin to Prevent Singleton Preterm Births: Current Knowledge and Clinical Advice.使用孕激素预防单胎早产的挑战：当前认知与临床建议
Int J Womens Health. 2024 Jan 22;16:119-130. doi: 10.2147/IJWH.S394305. eCollection 2024.
2
The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth.终点亦是起点：己酸17-α羟孕酮撤药预防复发性早产
Am J Obstet Gynecol. 2024 Jan;230(1):1-9. doi: 10.1016/j.ajog.2023.08.031. Epub 2023 Oct 3.
3
What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.现在怎么办？对己酸17-α羟孕酮预防复发性早产20多年临床及研究经验的批判性评估。
Am J Obstet Gynecol MFM. 2023 Oct;5(10):101108. doi: 10.1016/j.ajogmf.2023.101108. Epub 2023 Jul 30.
4
Addressing a broken drug pipeline for preterm birth: why early preterm birth is an orphan disease.解决早产的药物研发困境：为什么极早早产是孤儿病。
Am J Obstet Gynecol. 2023 Dec;229(6):647-655. doi: 10.1016/j.ajog.2023.07.042. Epub 2023 Jul 27.
5
Advances and challenges in studying the tissue-resident T cell compartment in the human female reproductive tract.研究人类女性生殖道组织驻留 T 细胞区室的进展和挑战。
Immunol Rev. 2023 Jul;316(1):52-62. doi: 10.1111/imr.13212. Epub 2023 May 4.
6
Progestogens for maintenance tocolysis in symptomatic women. A systematic review and meta-analysis.孕激素维持治疗在有症状的早产孕妇中的应用：系统评价和荟萃分析。
PLoS One. 2023 Feb 22;18(2):e0277563. doi: 10.1371/journal.pone.0277563. eCollection 2023.
7
Maternal-fetal conflict averted by progesterone- induced FOXP3+ regulatory T cells.孕酮诱导的FOXP3 +调节性T细胞避免母胎冲突。
iScience. 2022 May 13;25(6):104400. doi: 10.1016/j.isci.2022.104400. eCollection 2022 Jun 17.
8
Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success.孕激素受体信号在子宫内对于妊娠成功至关重要。
Cells. 2022 Apr 27;11(9):1474. doi: 10.3390/cells11091474.
9
In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.子宫内暴露于 17α-羟孕酮己酸酯与后代癌症风险。
Am J Obstet Gynecol. 2022 Jan;226(1):132.e1-132.e14. doi: 10.1016/j.ajog.2021.10.035. Epub 2021 Nov 9.
10
Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol.无症状高危且宫颈长度正常的孕妇应用阴道孕酮预防早产的系统评价和荟萃分析方案
Syst Rev. 2021 May 21;10(1):152. doi: 10.1186/s13643-021-01702-9.
本文引用的文献
1
The rebirth of progesterone in the prevention of preterm labor.孕激素在预防早产中的重生。
Ann Pharmacother. 2013 Apr;47(4):527-36. doi: 10.1345/aph.1R281. Epub 2013 Mar 27.
2
Prevention of preterm birth by progestational agents: what are the molecular mechanisms?孕激素制剂预防早产：分子机制是什么？
Am J Obstet Gynecol. 2013 Mar;208(3):223.e1-7. doi: 10.1016/j.ajog.2013.01.020.
3
Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.17α-羟孕酮己酸酯预防无症状双胎妊娠短宫颈早产：一项随机对照试验。
Am J Obstet Gynecol. 2013 Mar;208(3):194.e1-8. doi: 10.1016/j.ajog.2013.01.032.
4
A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.预防早产的蓝图：短宫颈孕妇的阴道用黄体酮。
J Perinat Med. 2013 Jan;41(1):27-44. doi: 10.1515/jpm-2012-0272.
5
Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor.比较早产和足月分娩中导致宫颈重塑的机制。
J Reprod Immunol. 2013 Mar;97(1):112-9. doi: 10.1016/j.jri.2012.07.008. Epub 2013 Jan 10.
6
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.绝经后激素治疗中使用的孕激素：其药理学特性、细胞内作用和临床效果的差异。
Endocr Rev. 2013 Apr;34(2):171-208. doi: 10.1210/er.2012-1008. Epub 2012 Dec 13.
7
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.17α-羟孕酮己酸酯预防宫颈长度小于 30mm 的初产妇早产。
Am J Obstet Gynecol. 2012 Nov;207(5):390.e1-8. doi: 10.1016/j.ajog.2012.09.013. Epub 2012 Sep 17.
8
Practice bulletin no. 130: prediction and prevention of preterm birth.第130号实践公告：早产的预测与预防
Obstet Gynecol. 2012 Oct;120(4):964-73. doi: 10.1097/AOG.0b013e3182723b1b.
9
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.17-羟己酸孕酮在单胎妊娠中的药理学和胎盘转运。
Am J Obstet Gynecol. 2012 Nov;207(5):398.e1-8. doi: 10.1016/j.ajog.2012.08.015. Epub 2012 Aug 16.
10
Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis.孕激素预防早产治疗的围产结局：一项荟萃分析。
Ultrasound Obstet Gynecol. 2012 Sep;40(3):257-66. doi: 10.1002/uog.11178. Epub 2012 Aug 2.
Zotero 插件